Fosamax, Mereck's super-drug for treatment of osteoporosis in women, is one of the most profitable drugs in the history of the pharmaceutical industry. But, is it's popularity due to it's efficacy or Merck's aggressive marketing?
Bahe Cook Cantley & Nefzger PLC attorneys Shawn Cantley, John Bahe & Brian Cook currently represent women who have suffered jaw bone death, known as osteonecrosis of the the jaw, allegedly caused by Fosamax use. A study reported on ABC news and in the prestigious New England Journal of Medicine links Fosamax usage to femur fractures in women. Jaw bone death and femur fractures are not things that the medical community saw very often before bisphosphonates, the class of drugs to which Fosamax belongs, came along. Now, Fosamax is being linked to a greater likelihood of esophagus cancer.
There have also been serious questions raised about whether Fosamax is effective at achieving it's purported purpose of preventing or minimizing osteoporosis.
Anyone wishing to know more about Fosamax and the legal implications of injury by this or other drugs can direct an inquiry to the author of this post by clicking on the name below.